Literature DB >> 32700956

Applying experimental therapeutics to examine cognitive and chronological vulnerabilities as mediators of acute outcomes in cognitive-behavioral therapy and light therapy for winter depression.

Kelly J Rohan1, Keith B Burt1, Julia Camuso1, Jessica Perez1, Jonah Meyerhoff1.   

Abstract

OBJECTIVE: We applied the experimental therapeutics approach to test whether acute treatment outcomes for winter seasonal affective disorder (SAD) are mediated by a cognitive mechanism in cognitive-behavioral therapy (CBT-SAD) versus a chronobiologic mechanism in light therapy (LT).
METHOD: Currently depressed adults with major depression, recurrent with seasonal pattern (N = 177; 83.6% female, 92.1% non-Hispanic White, M age = 45.6) were randomized to 6 weeks of LT or group CBT-SAD. SAD symptoms were assessed weekly on the Structured Clinical Interview for the Hamilton Rating Scale for Depression-SAD Version. At pre-, mid-, and posttreatment, participants completed measures of general depressogenic cognitions (Dysfunctional Attitudes Scale; DAS); SAD-specific negative cognitions (Seasonal Beliefs Questionnaire; SBQ); chronotype (Morningness-Eveningness Questionnaire; MEQ); and depressive symptoms (Beck Depression Inventory-Second Edition).
RESULTS: Parallel-process growth models showed evidence for hypothesized mechanisms. For SAD-specific negative cognitions (SBQ), both symptom measures showed (1) an effect of treatment group on the slope of the mediator, with CBT-SAD demonstrating greater decreases, and (2) an effect of the slope of the mediator on the slope of the outcome. These effects held for the SBQ but not the broader measure of depressogenic cognitions (DAS). For the chronotype measure (MEQ), treatment assignment affected change, whereby LT was associated with reduced "eveningness," but this was unrelated to change in symptoms.
CONCLUSIONS: CBT-SAD promoted decreases in SAD-specific negative cognitions, and these changes were related to decreases in symptoms. Consistent with the theory that LT corrects misaligned circadian rhythms, LT reduced eveningness, but this did not correspond to symptom improvement. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 32700956      PMCID: PMC7384243          DOI: 10.1037/ccp0000499

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  41 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms.

Authors:  J A Horne; O Ostberg
Journal:  Int J Chronobiol       Date:  1976

3.  Investigation of Mediational Processes Using Parallel Process Latent Growth Curve Modeling.

Authors:  Jeewon Cheong; David P Mackinnon; Siek Toon Khoo
Journal:  Struct Equ Modeling       Date:  2003-04-01       Impact factor: 6.125

4.  Randomized Trial of Cognitive-Behavioral Therapy Versus Light Therapy for Seasonal Affective Disorder: Acute Outcomes.

Authors:  Kelly J Rohan; Jennifer N Mahon; Maggie Evans; Sheau-Yan Ho; Jonah Meyerhoff; Teodor T Postolache; Pamela M Vacek
Journal:  Am J Psychiatry       Date:  2015-04-10       Impact factor: 18.112

Review 5.  Winter depression and the phase-shift hypothesis for bright light's therapeutic effects: history, theory, and experimental evidence.

Authors:  A J Lewy; R L Sack; C M Singer; D M White; T M Hoban
Journal:  J Biol Rhythms       Date:  1988       Impact factor: 3.182

6.  Pupillary and reaction time measures of sustained processing of negative information in depression.

Authors:  G J Siegle; E Granholm; R E Ingram; G E Matt
Journal:  Biol Psychiatry       Date:  2001-04-01       Impact factor: 13.382

Review 7.  Mechanisms of change in psychotherapy for depression: An empirical update and evaluation of research aimed at identifying psychological mediators.

Authors:  Lotte H J M Lemmens; Viola N L S Müller; Arnoud Arntz; Marcus J H Huibers
Journal:  Clin Psychol Rev       Date:  2016-09-20

8.  Circadian time of morning light administration and therapeutic response in winter depression.

Authors:  J S Terman; M Terman; E S Lo; T B Cooper
Journal:  Arch Gen Psychiatry       Date:  2001-01

9.  Sustained gamma-band EEG following negative words in depression and schizophrenia.

Authors:  Greg J Siegle; Ruth Condray; Michael E Thase; Matcheri Keshavan; Stuart R Steinhauer
Journal:  Int J Psychophysiol       Date:  2009-12-11       Impact factor: 2.997

10.  The circadian rhythm of temperature during light treatment for winter depression.

Authors:  C I Eastman; L C Gallo; H W Lahmeyer; L F Fogg
Journal:  Biol Psychiatry       Date:  1993-08-15       Impact factor: 13.382

View more
  4 in total

1.  Detecting Critical Decision Points during Cognitive-Behavioral Therapy and Light Therapy for Winter Depression Nonremission and Recurrence.

Authors:  Kelly J Rohan; Julia Camuso; Jessica Perez; Praise Iyiewuare; Jonah Meyerhoff; Michael J DeSarno; Pamela M Vacek
Journal:  J Behav Cogn Ther       Date:  2020-10-29

2.  Body mass index and atypical balance as predictors of winter depression remission in cognitive-behavioral therapy and light therapy.

Authors:  Praise Iyiewuare; Kelly J Rohan; Teodor T Postolache
Journal:  J Affect Disord       Date:  2021-09-25       Impact factor: 4.839

3.  Predictive validity of the Seasonal Beliefs Questionnaire for discriminating between seasonal and nonseasonal major depressive disorder.

Authors:  Kelly J Rohan; Jonah Meyerhoff; Kathryn A Roecklein; Michael J DeSarno; Pamela M Vacek
Journal:  Psychol Assess       Date:  2021-03-18

4.  Elucidating treatment targets and mediators within a confirmatory efficacy trial: study protocol for a randomized controlled trial of cognitive-behavioral therapy vs. light therapy for winter depression.

Authors:  Kelly J Rohan; Peter L Franzen; Kathryn A Roeckelin; Greg J Siegle; David J Kolko; Teodor T Postolache; Pamela M Vacek
Journal:  Trials       Date:  2022-05-12       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.